DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients

Clinical trial NCT06388122 · RECRUITING

Trial details

NCT number: NCT06388122
Sponsor: Mayo Clinic
Status: RECRUITING
Study type: OBSERVATIONAL

HER2-negative Breast Cancer Hormone-receptor-positive Breast Cancer Metastatic Breast Cancer Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 HER2 Negative Breast Carcinoma Hormone Receptor Positive Breast Carcinoma Metastatic Breast Carcinoma

Start date: 2024-04-30
Primary completion: 2031-06-15
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.